Diabetes in Japan: a review of disease burden and approaches to treatment
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
In recent years there has been rapid growth in diabetes in Japan which now is one of the nations most affected by the worldwide diabetes epidemic. Diabetes has been identified as a healthcare priority by the Ministry of Health, Labour and Welfare (MHLW). Type 1 diabetes is rare in Japan, and type 2 diabetes predominates in both adults and children. The growth in diabetes is due to increases in the number of people with type 2 diabetes associated with increased longevity and lifestyle changes. Approximately 13.5% of the Japanese population now has either type 2 diabetes or impaired glucose tolerance. This high prevalence of type 2 diabetes is associated with a significant economic burden, with diabetes accounting for up to 6% of the total healthcare budget. The costs of diabetes are increased in patients with co‐morbidities such as hypertension and hyperlipidaemia and in patients who develop complications, of which retinopathy has the highest cost. Costs increase with increasing number of complications. Current guidelines from the Japan Diabetes Society (JDS) recommend a target HbA 1c of 6.5% for glycaemic control. This is achieved in approximately one third of patients with type 2 diabetes, and Japanese patients typically have lower HbA 1c than patients in Western countries (e.g. US, UK). Japanese patients with type 2 diabetes have better adherence with diet and exercise recommendations than their peers in Western countries. Sulfonylureas have been the most widely prescribed first‐line treatment for type 2 diabetes, although there is increasing use of combination therapy and of insulin. Copyright © 2009 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global guideline for type 2 diabetes
(2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.10.001 · Cited by 1,064
Variants in KCNQ1 are associated with susceptibility to type 2 diabetes mellitus
Yasuda, K., Miyake, K., Horikawa, Y., Hara, K., Osawa, H., Furuta, H., Hirota, Y., Mori, H., Jonsson, A., Sato, Y., et al. (2008) · Nature Genetics · doi:10.1038/ng.207 · Cited by 776 · cited 1×
“HHEX and variants in the KCNQ1 gene are associated with susceptibility to type 2 diabetes in Western populations and are also type 2 diabetes susceptibility genes in Japanese subjects [19,22].”
Background
Cited by
Okamura, T., Hashimoto, Y., Hamaguchi, M., Obora, A., Kojima, T., & Fukui, M. (2019) · International Journal of Obesity · doi:10.1038/s41366-018-0076-3 · Cited by 325
A Wearable Cellulose Acetate-Coated Mouthguard Biosensor for In Vivo Salivary Glucose Measurement
Arakawa, T., Tomoto, K., Nitta, H., Toma, K., Takeuchi, S., Sekita, T., Minakuchi, S., & Mitsubayashi, K. (2020) · Analytical Chemistry · doi:10.1021/acs.analchem.0c01201 · Cited by 313
You, W.-P., & Henneberg, M. (2016) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2015-000161 · Cited by 257
Sakane, N., Kotani, K., Takahashi, K., Sano, Y., Tsuzaki, K., Okazaki, K., Sato, J., Suzuki, S., Morita, S., Oshima, Y., et al. (2015) · BMJ Open · doi:10.1136/bmjopen-2014-007316 · Cited by 40
Kiyosue, A., Dunn, J. P., Cui, X., Hickey, A., Hirase, T., Imaoka, T., & Heine, R. J. (2023) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14952 · Cited by 30
“In addition to rising rates of obesity and overweight,(15) the ageing of the population in East Asian countries is fuelling the diabetes epidemic, especially in countries such as Japan, which is termed ‘super-aged’.(16,17) The value of weight loss in older patients with type 2 diabetes has been debated,(18,19) but rec…”
BackgroundAssociation of sleep duration with untreated diabetes in Japanese men
Kachi, Y., Ohwaki, K., & Yano, E. (2012) · Sleep Medicine · doi:10.1016/j.sleep.2011.04.008 · Cited by 28
Daida, H., Teramoto, T., Kitagawa, Y., Matsushita, Y., Sugihara, M., & APPROACH-J Study Group (2014) · International Heart Journal · doi:10.1536/ihj.13-002 · Cited by 12
Watada, H., Imori, M., Li, P., & Iwamoto, N. (2017) · Endocrine Journal · doi:10.1507/endocrj.ej17-0020 · Cited by 2
Metadata
- Authors
- Neville, S. E., Boye, K. S., Montgomery, W. S., Iwamoto, K., Okamura, M., & Hayes, R. P.
- Venue
- Diabetes/Metabolism Research and Reviews
- Publisher
- Wiley
- Published
- 2009-09-30
- Volume
- 25
- Issue
- 8
- Pages
- 705-716
- ISSN
- 1520-7552 (ISSN-L)
- 1520-7560
- OpenAlex
- W2097132878
- Cited by
- 150
- References
- 2
- FWCI
- 4.57
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.